Business

Export-focused drugmaker Dr. Reddy's Laboratories Ltd(REDY.NS) said it was in talks with a U.S. regulator over allegations it violated packaging rules for some prescription drugs sold there between 2008 and 2012.The allegations by the U.S. government's Consumer Product Safety Commission (CPSC) are the latest in a series of regulatory troubles facing Indian pharmaceutical firms in their biggest export market, the United States.

Reuters noted from the company's quarterly report filed August 14 for its investors that it will not be proceeding with its appeal of a federal safety ruling that would prevent trainers from getting into the pools with their orca charges.

The announcement was made by Attorney General Eric Holder in Washington on Thursday morning, the New York Times reported. Holder said that the Bank of America is expected to pay $9.65 billion as cash penalty and will also provide $7 billion to blighted neighborhoods and homeowners as relief to counter the damage the securities have cost.